NDC 72205-034-45 - Lacosamide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72205-034
- Requested NDC
- 72205-034-45
- Package NDCs from labels
- 72205-034-75, 72205-034-74, 72205-034-44, 72205-034-50, 72205-034-45, 72205-034-91, 72205-034-46, 72205-034-93, 72205-034-47, 72205-034-94
- Manufacturer
- Novadoz Pharmaceuticals LLC | MSN Pharmaceuticals Inc.
- Effective date
- 2026-08-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lacosamide - Novadoz Pharmaceuticals LLC | MSN Pharmaceuticals Inc. | Novadoz Pharmaceuticals LLC | MSN Pharmaceuticals Inc. | 2026-08-12 | Human Prescription Drug Label |
| Lacosamide - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-05-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72205-034-44 | Lacosamide | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 2 | |
| 72205-034-45 | Lacosamide | 10 mL in 1 CUP, UNIT-DOSE | SOLUTION | 10 | 2 | |
| 72205-034-46 | Lacosamide | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 2 | |
| 72205-034-47 | Lacosamide | 20 mL in 1 CUP, UNIT-DOSE | SOLUTION | 20 | 2 | |
| 72205-034-50 | Lacosamide | 1 in 1 BOX | SOLUTION | 1 | 2 | |
| 72205-034-50 | Lacosamide | 10 in 1 TRAY | SOLUTION | 10 | 2 | |
| 72205-034-74 | Lacosamide | 200 mL in 1 BOTTLE, PLASTIC | SOLUTION | 200 | 2 | |
| 72205-034-75 | Lacosamide | 465 mL in 1 BOTTLE, PLASTIC | SOLUTION | 465 | 2 | |
| 72205-034-91 | Lacosamide | 1 in 1 BOX | SOLUTION | 1 | 2 | |
| 72205-034-91 | Lacosamide | 10 in 1 TRAY | SOLUTION | 10 | 2 | |
| 72205-034-93 | Lacosamide | 1 in 1 BOX | SOLUTION | 1 | 2 | |
| 72205-034-93 | Lacosamide | 10 in 1 TRAY | SOLUTION | 10 | 2 | |
| 72205-034-94 | Lacosamide | 10 in 1 TRAY | SOLUTION | 10 | 2 | |
| 72205-034-94 | Lacosamide | 1 in 1 BOX | SOLUTION | 1 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72205-034-74 | ML - Milliliter | 72205-034 | 6494c70d-1486-4450-81e9-54481a0c8e9e | 1 | 2024-07-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TheraTears Lubricant | CARBOXYMETHYLCELLULOSE SODIUM | MEDTECH PRODUCTS INC | 797b0394-2f0f-4733-8d20-ec5bdf3e085d | 2025-10-23 | Warnings | K679OBS311 |
| Lemon Glycerine Swabsticks | GLYCERINE | PHOENIX HEALTHCARE SOLUTIONS, LLC | 436919f7-14cd-4318-9388-b3e1cbec176b | 2025-10-23 | Warnings | PDC6A3C0OX |
| miranda castros HEALING FOR INSECT BITES AND STINGS | CALENDULA OFFICINALIS, CALADIUM SEGUINUM, LEDUM PALUSTRE, NATRUM MURIATICUM, PLANTAGO MAJOR, STAPHYSAGRIA, URTICA URENS | MIRANDA CASTRO'S SHOP, LLC | 1f99d32e-2394-411a-e063-6294a90ac454 | 2025-10-23 | Warnings | 451W47IQ8X |
| Advanced Eye Relief Dry Eye Rejuvenation | GLYCERIN PROPYLENE GLYCOL | Bausch & Lomb Incorporated | 027969ee-64e4-4b08-bab7-c4cc8ed22f5f | 2025-10-23 | Warnings | 6DC9Q167V3 PDC6A3C0OX |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | ICU Medical Inc. | b96eb740-749a-4d3a-ae63-b8e3947cad30 | 2025-10-23 | Warnings, Adverse reactions | 451W47IQ8X |
| TheraTears Lubricant | CARBOXYMETHYLCELLULOSE SODIUM | MEDTECH PRODUCTS INC | 661d8764-8ae6-4229-9485-867553ee8e16 | 2025-10-23 | Warnings | K679OBS311 |
| Sterile Water | WATER | Becton Dickinson and Company | cab03cda-4660-4020-a3be-bf86242ff664 | 2025-10-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Refresh Relieva Preservative Free | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 3481f9b3-5a90-40d3-80f8-81f51cc864be | 2025-10-22 | Warnings | PDC6A3C0OX K679OBS311 |
| Sodium Chloride Normal Salt | SODIUM CHLORIDE | Method Pharmaceuticals | ce84727a-3677-4bf0-e053-2995a90a3ec8 | 2025-10-21 | Warnings | 451W47IQ8X |
| Lacosamide | LACOSAMIDE | Kanchan Healthcare Inc | 5c03b90e-6985-4005-b6c5-44626d0600d7 | 2025-10-19 | Warnings, Adverse reactions | 563KS2PQY5 |
| Walgreens Antacid Pain Relief Extra Strength | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walgreens | b60df498-07db-500b-e053-2a95a90aff6a | 2025-10-17 | Warnings | XF417D3PSL |
| Equate Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walmart | 6271b34b-55a0-40a8-e053-2a91aa0acb22 | 2025-10-17 | Warnings, Adverse reactions | XF417D3PSL |
| Walgreens Ultra Lubricant | POLYETHYLENE GLYCOL 400, AND PROPYLENE GLYCOL | Walgreens | 21dfe061-4533-2061-e063-6394a90a6e73 | 2025-10-17 | Warnings | 6DC9Q167V3 |
| Walgreens | SODIUM CHLORIDE | Walgreen Company | 21dfc2cf-65ae-c3fb-e063-6294a90a0a94 | 2025-10-17 | 451W47IQ8X | |
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 4694f05b-d927-4e15-9630-a0a1cddb3cbb | 2025-10-16 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Amerisource Bergen/Good Neighbor Pharmacy | e6a8914f-cfd9-4c72-abaa-22189bf0faef | 2025-10-16 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 3386fada-6b7f-46fd-e063-6294a90abffc | 2025-10-16 | Warnings | PDC6A3C0OX |
| Homeopathic Tea Tree Oil Lice | EUCALYPTUS GLOBULUS, NATRUM MURIATICUM | DOLGENCORP, LLC | 0a0c2db2-7eeb-909c-e063-6394a90a7a90 | 2025-10-15 | Warnings | 451W47IQ8X |
| Finafta | BENZOCAINE, GLYCERIN | Efficient Laboratories Inc. | 03368603-3e11-c2fa-e063-6294a90a04ea | 2025-10-14 | Warnings | PDC6A3C0OX |
| Saline Ampoules | SODIUM CHLORIDE 0.9% | Trifecta Pharmaceuticals USA, LLC. | ee18ef7c-bb5d-30ec-e053-2a95a90a964e | 2025-10-13 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.